-
Merger Twist - S&P Upgrades Sanofi Aventis (SNY) to Buy
Wednesday, September 1, 2010 - 1:25pm | 269Read More...It’s unusual for analysts to upgrade the stock of an acquirer during merger talks. Especially since most analysts think that Sanofi Aventis (NYSE: SNY) will raise its bid for Genzyme (NASDAQ: GENZ) But S&P raised Sanofi to Buy from Hold yesterday. The upgrade was most likely a reaction to...
-
S&P Raise Genzyme (GENZ) to Buy from Hold
Wednesday, August 4, 2010 - 1:57pm | 162Read More...S&P raised Genzyme (NASDAQ: GENZ) to a Buy from Hold in the Aug. 4, edition of The Outlook, based on reports that Sanofi Aventis (NYSE: SNF) is going to acquire Genzyme. In a related story, Shire’s CEO, Angus Russell said of the proposed merger, “I'm not sure it changes anything in regards to...
-
Gary Motyl of Templeton is Bullish – Likes BP (BP) & Sanofi (SNY)
Tuesday, March 23, 2010 - 7:35pm | 442Read More...Gary Motyl of Templeton Global Equity was the Market Monitor on Friday, March 19, 2010, on Nightly Business Report. Motyl is generally bullish. “While you have had some valuation pressure over the last 12 months, we're still finding value in literally every industry and sector around the world. We...
-
William Blair Reiterates Outperform Rating Of PetMed Express (PETS)
Monday, March 15, 2010 - 9:06am | 199Read More...William Blair & Company analysts Daniel Hofkin and Mark Miller reiterated their Outperform rating for shares of PetMed Express, Inc. (Nasdaq: PETS). The analysts said that a recent decision by BAYER AKTIENGES (OTC: BAYRY.PK) to broaden its distribution to over the counter sales would produce...
